Literature DB >> 2450951

Expression and characterization of a truncated murine Fc gamma receptor.

Z X Qu1, J Odin, J D Glass, J C Unkeless.   

Abstract

We have isolated a recombinant secreted Fc gamma R beta molecule by deletion of the transmembrane and cytoplasmic domains encoding sequence from a Fc gamma R beta 1 cDNA clone, and insertion of the truncated cDNA into a eukaryotic expression vector, pcEXV-3. To express and amplify the production of the truncated Fc gamma R beta molecule, we transfected the truncated cDNA plasmid into a dihydrofolate reductase-minus CHO cell line along with a dhfr minigene, and amplified the gene products with methotrexate. The resulting cell line secretes 2-3 micrograms/ml/24 h of truncated Fc gamma R beta, which can be readily purified by affinity chromatography on IgG-Sepharose. The truncated Fc gamma R beta has a Mr of 31-33,000 on SDS-PAGE and is glycosylated. N-glycosidase F cleavage reduces the Mr to 19,000, consistent with the size of the truncated product, 176 amino acid residues. There are two disulfide bonds in the protein. Binding of immune complexes formed between DNP20BSA and anti-DNP mAbs reveals better binding of IgG1 aggregates than that of IgG2b and IgG2a aggregates. The binding of the immune complexes was somewhat better at more acidic pH, in contrast to previous experiments with binding of purified Fc gamma R to immune complex-coated beads. We were surprised to observe that the truncated Fc gamma R beta did not react with the anti-Fc gamma R mAb 6B7C. Previous work had shown that 6B7C reacts with Fc gamma R on immunoblots, fails to bind to the surface of resting B cells and peritoneal macrophages, but does bind to macrophage cell lines and LPS-stimulated B cells. We show, by binding of mAb 6B7C to a peptide conjugate, that the 6B7C epitope lies within residues 169-183 of the intact Fc gamma R beta, which is just outside the plasma membrane. The availability of the truncated Fc gamma R beta in microgram quantities should facilitate further analysis of structure and function of these receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450951      PMCID: PMC2188870          DOI: 10.1084/jem.167.3.1195

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  A new method for disulfide analysis of peptides.

Authors:  W L Anderson; D B Wetlaufer
Journal:  Anal Biochem       Date:  1975-08       Impact factor: 3.365

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Soluble circulating Fc gamma receptors in human serum. A new ELISA assay for specific and quantitative detection.

Authors:  D Khayat; C Geffrier; S Yoon; E Scigliano; C Soubrane; M Weil; J C Unkeless; C Jacquillat
Journal:  J Immunol Methods       Date:  1987-06-26       Impact factor: 2.303

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

6.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

7.  A complementary DNA clone for a macrophage-lymphocyte Fc receptor.

Authors:  V A Lewis; T Koch; H Plutner; I Mellman
Journal:  Nature       Date:  1986 Nov 27-Dec 3       Impact factor: 49.962

8.  Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.

Authors:  R J Youle; D M Neville
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

9.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

10.  Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.

Authors:  J C Unkeless
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

View more
  7 in total

Review 1.  Function and heterogeneity of human Fc receptors for immunoglobulin G.

Authors:  J C Unkeless
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

Review 2.  Fc receptor-mediated signal transduction.

Authors:  C T Lin; Z Shen; P Boros; J C Unkeless
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

3.  Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction.

Authors:  F L Ierino; M S Powell; I F McKenzie; P M Hogarth
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

4.  Autoimmune mice make anti-Fc gamma receptor antibodies.

Authors:  P Boros; J M Chen; C Bona; J C Unkeless
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

5.  A small number of anti-CD3 molecules on dendritic cells stimulate DNA synthesis in mouse T lymphocytes.

Authors:  N Romani; K Inaba; E Puré; M Crowley; M Witmer-Pack; R M Steinman
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

6.  The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands.

Authors:  M S Diamond; J Garcia-Aguilar; J K Bickford; A L Corbi; T A Springer
Journal:  J Cell Biol       Date:  1993-02       Impact factor: 10.539

7.  IgM anti-Fc gamma R autoantibodies trigger neutrophil degranulation.

Authors:  P Boros; J A Odin; T Muryoi; S K Masur; C Bona; J C Unkeless
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.